Transcatheter closure of patent ductus arteriosus

Medical Services Advisory Committee
Record ID 32015000426
English
Authors' recommendations: After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of transcatheter closure of PDA, MSAC supports public funding via a new MBS item, with an MBS fee of $912.30 and an item descriptor of: Category 3 – Cardio-Thoracic PATENT DUCTUS ARTERIOSUS, Transcatheter closure of, including cardiac catheterisation and any imaging associated with the service (Anaes.) (Assist.) Fee: $912.30 Benefit: 75% = $684.25
Details
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Cardiac Catheterization
Contact
Organisation Name: Medical Services Advisory Committee
Contact Address: MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name: msac.secretariat@health.gov.au
Contact Email: msac.secretariat@health.gov.au
Copyright: Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.